| In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking. T Joshi, P Sharma, S Mathpal, H Pundir, V Bhatt, S Chandra European Review for Medical & Pharmacological Sciences 24 (8), 2020 | 233 | 2020 |
| Molecular docking and molecular dynamics simulation approach to screen natural compounds for inhibition of Xanthomonas oryzae pv. Oryzae by targeting … T Joshi, T Joshi, P Sharma, S Chandra, V Pande Journal of Biomolecular Structure and Dynamics 39 (3), 823-840, 2021 | 94 | 2021 |
| In silico screening of potential antidiabetic phytochemicals from Phyllanthus emblica against therapeutic targets of type 2 diabetes P Sharma, T Joshi, T Joshi, S Chandra, S Tamta Journal of ethnopharmacology 248, 112268, 2020 | 82 | 2020 |
| Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19 T Joshi, P Sharma, T Joshi, H Pundir, S Mathpal, S Chandra Molecular Diversity 25, 1665-1677, 2021 | 59 | 2021 |
| In silico screening of anti-inflammatory compounds from Lichen by targeting cyclooxygenase-2 T Joshi, P Sharma, T Joshi, S Chandra Journal of Biomolecular Structure and Dynamics 38 (12), 3544-3562, 2020 | 51 | 2020 |
| Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease T Joshi, T Joshi, H Pundir, P Sharma, S Mathpal, S Chandra Journal of Biomolecular Structure and Dynamics 39 (17), 6728-6746, 2021 | 48 | 2021 |
| Molecular dynamics simulation for screening phytochemicals as α-amylase inhibitors from medicinal plants P Sharma, T Joshi, T Joshi, S Chandra, S Tamta Journal of Biomolecular Structure and Dynamics 39 (17), 6524-6538, 2021 | 46 | 2021 |
| A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor S Mathpal, T Joshi, P Sharma, T Joshi, H Pundir, V Pande, S Chandra Journal of Biomolecular Structure and Dynamics 40 (3), 1084-1100, 2022 | 27 | 2022 |
| Molecular basis for the repurposing of histamine H2-receptor antagonist to treat COVID-19 AA Ishola, T Joshi, SI Abdulai, H Tijjani, H Pundir, S Chandra Journal of Biomolecular Structure and Dynamics 40 (13), 5785-5802, 2022 | 20 | 2022 |
| Identification of Berbamine, Oxyacanthine and Rutin from Berberis asiatica as anti-SARS-CoV-2 compounds: An in silico study T Joshi, S Bhat, H Pundir, S Chandra Journal of Molecular Graphics and Modelling 109, 108028, 2021 | 19 | 2021 |
| QSAR modeling and pharmacoinformatics of SARS coronavirus 3C-like protease inhibitors AA Ishola, O Adedirin, T Joshi, S Chandra Computers in biology and medicine 134, 104483, 2021 | 19 | 2021 |
| Screening of potential bio-molecules from Moringa olifera against SARS-CoV-2 main protease using computational approaches S Mathpal, P Sharma, T Joshi, T Joshi, V Pande, S Chandra Journal of Biomolecular Structure and Dynamics 40 (20), 9885-9896, 2022 | 15 | 2022 |
| Computational investigation of drug bank compounds against 3C-like protease (3CLpro) of SARS-CoV-2 using deep learning and molecular dynamics simulation T Joshi, P Sharma, S Mathpal, T Joshi, P Maiti, M Nand, V Pande, ... Molecular Diversity, 1-14, 2022 | 14 | 2022 |
| In silico identification of natural fungicide from Melia azedarach against isocitrate lyase of Fusarium graminearum T Joshi, T Joshi, P Sharma, H Pundir, S Chandra Journal of Biomolecular Structure and Dynamics 39 (13), 4816-4834, 2021 | 13 | 2021 |
| Using Chou’s 5-steps rule to study pharmacophore-based virtual screening of SARS-CoV-2 Mpro inhibitors H Pundir, T Joshi, T Joshi, P Sharma, S Mathpal, S Chandra, S Tamta Molecular Diversity 25, 1731-1744, 2021 | 12 | 2021 |
| In silico screening of natural compounds to inhibit interaction of human ACE2 receptor and spike protein of SARS-CoV-2 for the prevention of COVID-19 P Sharma, T Joshi, T Joshi, S Mathpal, P Maiti, M Nand, S Chandra, ... Journal of Biomolecular Structure and Dynamics 41 (2), 646-658, 2023 | 8 | 2023 |
| Repurposing of FDA approved drugs against Salmonella enteric serovar Typhi by targeting dihydrofolate reductase: an in silico study T Joshi, P Sharma, T Joshi, S Mathpal, V Pande, S Chandra Journal of Biomolecular Structure and Dynamics 40 (8), 3731-3744, 2022 | 8 | 2022 |
| Deep-learning based repurposing of FDA-approved drugs against Candida albicans dihydrofolate reductase and molecular dynamics study T Joshi, H Pundir, S Chandra Journal of Biomolecular Structure and Dynamics 40 (18), 8420-8436, 2022 | 6 | 2022 |
| Recent advances on computational approach towards potential drug discovery against leishmaniasis T Joshi, P Sharma, T Joshi, S Mathpal, SC Pandey, A Pandey, S Chandra Pathogenesis, treatment and prevention of Leishmaniasis, 63-84, 2021 | 5 | 2021 |
| A spotlight on the recent advances in bacterial plant diseases and their footprint on crop production T Joshi, P Sharma, T Joshi, SC Pandey, V Pande, A Pandey, D Joshi, ... Recent Advancements in Microbial Diversity, 37-69, 2020 | 5 | 2020 |
